Isolation and characterization of human antibodies targeting human aspartyl (asparaginyl) β-hydroxylase

Human Antibodies

Volumn 16, Issue 3-4, 2007, Pages 163-176

  Yeung, Y A ^a   Finney, A H ^b   Koyrakh, I A ^a   Lebowitz, M S ^b   Ghanbari, H A ^b   Wands, J R ^c   Wittrup, K D ^a,d  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b Panacea Pharmaceuticals Inc   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Human antibody; Human aspartyl asparaginyl hydroxylase; Immunotoxin; Internalization; Targeting

Indexed keywords

ASPARTYLASPARAGININE BETA HYDROXYLASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1 ANTIBODY; OXYGENASE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; CYTOTOXICITY; ENZYME BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE;

EID: 40549144335     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2007-163-410     Document Type: Article

References (50)